Amgen
AMGN
#103
Rank
NZ$257.05 B
Marketcap
$478.21
Share price
1.18%
Change (1 day)
8.93%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Amgen (AMGN) Fails to deliver data

Key failure to deliver metrics for Amgen:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Amgen (AMGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Amgen (AMGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Amgen (AMGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$0.24 B0.14%
2023NZ$0.24 B-52.05%
2022NZ$0.51 B157.37%
2021NZ$0.19 B22.68%
2020NZ$0.16 B98.48%
2019NZ$81.68 M-82.11%
2018NZ$0.45 B188.65%
2017NZ$0.15 B-34.3%
2016NZ$0.24 B-7.34%
2015NZ$0.25 B105.33%
2014NZ$0.12 B171.37%
2013NZ$46.63 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$47.84 MNZ$0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$42.83 MNZ$0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$56.6 MNZ$97.55 M๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$29.7 MNZ$0.22 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.9 MNZ$72.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$82.85 MNZ$0.16 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$81.26 MNZ$0.34 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$46.96 MNZ$69.82 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$75.76 MNZ$0.17 B๐Ÿ‡บ๐Ÿ‡ธ USA